Binzhou Huijia Biotechnology Co., Ltd. announced that it will raise CNY 113,000,000 in a round of funding on July 7, 2023. The transaction will include participation from returning investor Shandong Teamgene Technology Co., Ltd. for CNY 57,630,000, and new investor Qingdao Xiaozhi Biotechnology Co., Ltd for CNY 55,370,000. The transaction has been approved in the 16th Meeting of the Company?s 1st Directorate and the 14th Meeting of the 1st Supervisory Board held on July 7, 2023, and is subject to the Shareholders?

Approval.